Optiver Holding B.V. Bausch Health Companies Inc. Transaction History

Optiver Holding B.V.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$7.77 - $10.61 $15,641 - $21,357	2,013 Added 2757.53%	2,086 $22,000
Q4 2023 Feb 13, 2024	BUY	$6.53 - $8.23 $476 - $600	73 New	73 $0
Q1 2023 May 11, 2023	BUY	$6.28 - $9.85 $10,223 - $16,035	1,628 New	1,628 $13,000
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $16,268 - $32,713	3,552 Added 707.57%	4,054 $28,000
Q2 2022 Aug 10, 2022	BUY	$7.06 - $23.63 $2,824 - $9,452	400 Added 392.16%	502 $4,000
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $3,758 - $4,835	-174 Reduced 63.04%	102 $2,000
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $6,911 - $8,296	276 New	276 $8,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.